Lauren E. Lee
No Rating Available
(Learn About Our Rating System)

Lauren E. Lee, MD, FACP

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Research North

Clinic 2D/E, BMT/Hematology
Salt Lake City
801-587-7000

  • Dr. Lauren Lee is a Clinical Associate Professor of Medicine in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine at the University of Utah School of Medicine. Her Bachelor of Science degrees in Biochemistry & Molecular Biology and Microbiology & Cell Science were awarded summa cum laude from the University of Florida. Dr. Lee completed her medical training at the University of Florida College of Medicine and was elected to the Alpha Omega Alpha Honor Medical Society before commissioning into the United States Air Force which took her to San Antonio for Internal Medicine Residency, Hematology and Medical Oncology Fellowship along with additional training in Bone Marrow Transplantation.

    With an interest in medical education, Dr. Lee served as Chief of Internal Medicine Residents and later became a Clinical Associate Professor of Medicine at the Uniformed Services University School of Medicine and a Core Teaching Faculty member for the San Antonio Uniformed Services Health Education Consortium Hem/Onc Fellowship Program. During her military service with the 59th Medical Wing, she took a special interest in developing radiation injury plans for joint special operators and later served as the Chief of Hematology/Oncology and the Director for Bone Marrow Transplantation at Brooke Army Medical Center. Dr. Lee has several publications, she has been a PI for various cancer clinical trials, and was awarded a Meritorious Service Medal prior to completing her military service as a Lieutenant Colonel. Choosing to continue her service in a different capacity, Dr. Lee joined the Huntsman Cancer Institute in September 2024. She is passionate about delivering high-quality, patient-centered care and has an interest in expanding community access to Cellular Therapies.

    For questions regarding Dr. Lee's practice, our clinical programs or for help identifying the right Hematology specialist for you or for your family member, please feel free to contact our Clinical Care Specialist/New Patient Coordinator at (801) 585-6906.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)

  • Dr. Lauren Lee is a Clinical Associate Professor of Medicine in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine at the University of Utah School of Medicine. Her Bachelor of Science degrees in Biochemistry & Molecular Biology and Microbiology & Cell Science were awarded summa cum laude from the University of Florida. Dr. Lee completed her medical training at the University of Florida College of Medicine and was elected to the Alpha Omega Alpha Honor Medical Society before commissioning into the United States Air Force which took her to San Antonio for Internal Medicine Residency, Hematology and Medical Oncology Fellowship along with additional training in Bone Marrow Transplantation.

    With an interest in medical education, Dr. Lee served as Chief of Internal Medicine Residents and later became a Clinical Associate Professor of Medicine at the Uniformed Services University School of Medicine and a Core Teaching Faculty member for the San Antonio Uniformed Services Health Education Consortium Hem/Onc Fellowship Program. During her military service with the 59th Medical Wing, she took a special interest in developing radiation injury plans for joint special operators and later served as the Chief of Hematology/Oncology and the Director for Bone Marrow Transplantation at Brooke Army Medical Center. Dr. Lee has several publications, she has been a PI for various cancer clinical trials, and was awarded a Meritorious Service Medal prior to completing her military service as a Lieutenant Colonel. Choosing to continue her service in a different capacity, Dr. Lee joined the Huntsman Cancer Institute in September 2024. She is passionate about delivering high-quality, patient-centered care and has an interest in expanding community access to Cellular Therapies.

    For questions regarding Dr. Lee's practice, our clinical programs or for help identifying the right Hematology specialist for you or for your family member, please feel free to contact our Clinical Care Specialist/New Patient Coordinator at (801) 585-6906.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Hematology & Hematologic Malignancies
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)

    Education history

    Fellowship Hematology, Medical Oncology & Bone Marrow Transplant - San Antonio Uniformed Services Health Education Consortium Fellow
    Residency Internal Medicine - San Antonio Uniformed Services Health Education Consortium Resident
    Professional Medical Medicine - University of Florida College of Medicine M.D.
    Undergraduate Biochemistry & Molecular Biology - University of Florida B.S.
    Undergraduate Major: Microbiology & Cell Science; Minor: Chemistry - University of Florida B.S.

    Selected Publications

    Journal Article

    1. Stoll KE, Lee LE (2021). Posterior reversible leukoencephalopathy syndrome in patients with hematopoietic stem cell transplant (HSCT)-associated thrombotic microangiopathy (TA-TMA). Journal of Case Reports and Images in Oncology, 7.
    2. Bowling GC, Ryden NA, Holmes AR, Lee LE, Stoll, KS (2024). A unique case of a compound heterozygosity of hemoglobin Korle-Bu and sickle cell trait in a military trainee. J Hematol, 13(3), 116-120.
    3. Christensen BR, Kou CJ, Lee LE (2024). A rare case of extranodal natural killer/t-cell lymphoma, nasal type associated with hemophagocytic lymphohistiocytosis in a patient with recurrent sinusitis. Cureus, 16(3), e5623.
    4. Vu ML, Stoll KE, Lee LE (2023). Safe and effective use of cabozantinib and nivolumab in stabilizing disease progression of tissue sarcoma after multiple lines of standard therapy. Journal of Case Reports and Images in Oncology, 9(2), 1-6.
    5. Vu MLD, Berman A, Kao E, Stoll K, Lee L (2023). Safe and effective use of cabozantinib and nivolumab in stabilizing disease progression of tissue sarcoma after multiple lines of standard therapy. Journal of Case Reports and Images in Obstetrics and Gynecology, 9(2), 1-6.
    6. Zakharian LM, Lee LE (2021). Successful Use of Immunotherapy in a Patient with Metastatic Squamous Cell Lung Cancer and Underlying Autoimmune Disease. Cureus, 13(6), e15918.
    7. Zakharian L, Lee L (2021). Successful Use of Immunotherapy in a Patient with Metastatic Squamous Cell Lung Cancer and Underlying Autoimmune Disease. Cureus, 13(6), e15918. (Read full article)
    8. Stoll KE, Lee L (2021). Posterior reversible encephalopathy syndrome in a patient with hematopoietic stem cell transplant (HSCT)-associated thrombotic microangiopathy (TA-TMA). Journal of Case Reports and Images in Obstetrics and Gynecology, 7, 100085Z10KS2021.
    9. Lee LE, Beeler BW, Graham BC, Cap AP, Win N, Chen F (2019). Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab. Transfusion, 60(1), 30-35. (Read full article)
    10. Lee LE, Barsoumian AE, Brown AW, Wiggins MA, Renshaw JS, Osswald MB, Murray CK (2016). Rates of Microbiologically Diagnosed Infection and Pathogen Detection in Hematopoietic Stem Cell Transplant Patients. Mil Med, 181(11), e1685-e1691. (Read full article)

    Abstract

    1. Ancira GA, Lee LE, Osswald MB (February 2023). Letermovir use for primary and secondary prophylaxis and pre-emptive therapy to prevent cytomegalovirus disease in allogeneic hematopoietic stem cell transplantation: a single bone marrow transplant center quality improvement initiative. [Abstract]. 29(2), S154.
    2. Lee LE, Peterson MR, Baur RA, Osswald MB (March 2019). Factors influencing acute leukemia relapse: a single-center look at post-transplant maintenance therapy. [Abstract]. 25(3), S113.
    3. Ciuro J, Henry E, Housri, N, Lee LE, et al (2022). Closing the gap: implementation of a novel interactive virtual tumor board to improve expert knowledge sharing in malignant hematology [Abstract]. 140(Supplement 1), 13180-13181.
    4. Lee LE, Beeler BW, Henderson AT, Graham BC, Osswald MB, Win N, Cap AP (2018). Targeting macrophage activation in hyperhemolysis syndrome with novel use of Tocilizumab [Abstract]. 132(Supplement 1), 4933.
    5. Wallace MR, Menke LE (2007). Cancer Society R.G. Thompson Memorial Summer Research Fellow; Mutational analysis of the Epi-2 promoter in myeloid leukemia [Abstract].

    Other

    1. Lee LE, Osswald MB (2014). Autologous peripheral blood stem cell transplant-induced functional asplenia in a patient with mantle cell lymphoma. Image Bank Set # 30971-2.